Vector Shedding and Blood Biodistribution in Patients with Severe Hemophilia a Following Administration of Valoctocogene Roxaparvovec

被引：0
|
作者：
Clark, Annie
Hammon, Kevin
Sandza, Krystal
Torres, Richard
Koziol, Elli
Holcomb, Jennifer
Kim, Benjamin
Jayaram, Kala
Russell, Chris
Vettermann, Christian
Henshaw, Joshua
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-136459
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] TRAFFICKING AND BIODISTRIBUTION OF AUTOLOGOUS PERIPHERAL-BLOOD MONOCYTES IN NORMAL DONORS AND CANCER-PATIENTS AFTER INTRAVENOUS ADMINISTRATION
    STEVENSON, HC
    MILLER, PJ
    ALVORD, G
    KEENAN, A
    LARSON, S
    LACERNA, L
    SMITH, J
    LONGO, DL
    JOURNAL OF LEUKOCYTE BIOLOGY, 1987, 42 (04) : 355 - 355
  • [42] Phenotypic correction of a hemophilia B dog following systemic administration of a helper-dependent ad vector encoding canine coagulation factor IX
    Brunetti-Pierri, N
    Palmer, D
    Nichols, TC
    Beaudet, AL
    Ng, P
    MOLECULAR THERAPY, 2004, 9 : S62 - S63
  • [43] Effect of factor VIII concentration on the risk of spontaneous bleeding following treatment with rFVIII (turoctocog alfa) in patients with severe hemophilia A
    Agerso, Henrik
    Matytsina, Irina
    Tripkovic, Nikola
    Overgaard, Rune Viig
    HAEMOPHILIA, 2016, 22 : 46 - 46
  • [44] Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS
    Lainas, G. T.
    Kolibianakis, E. M.
    Sfontouris, I. A.
    Zorzovilis, I. Z.
    Petsas, G. K.
    Lainas, T. G.
    Tarlatzis, B. C.
    HUMAN REPRODUCTION, 2013, 28 (07) : 1929 - 1942
  • [45] Stable Factor IX Activity Following AAV-mediated Gene Transfer in Patients with Severe Hemophilia B.
    Nathwani, Amit
    HUMAN GENE THERAPY, 2012, 23 (10) : A16 - A16
  • [46] CHANGES IN BLOOD-GAS LEVELS FOLLOWING NEBUHALER AND NEBULIZER ADMINISTRATION OF TERBUTALINE IN SEVERE CHRONIC AIRWAYS OBSTRUCTION
    HIGGINS, RM
    COOKSON, WOCM
    CHADWICK, GA
    CLINICAL SCIENCE, 1986, 71 : P36 - P36
  • [47] Longitudinal Antibody Signatures Following FVIII Replacement Therapy in Previously Untreated Patients with Severe Hemophilia A- New Insights from the Hemophilia Inhibitor PUP Study (HIPS)
    Gangadharan, Bagirath
    Reipert, Birgit
    Scheiflinger, Fritz
    Bowen, Joel
    Donnachie, Elizabeth
    van Draat, Karin Fijn
    Gruppo, Ralph A.
    Klintman, Jenny
    Male, Christoph
    McGuinn, Catherine E.
    Meeks, Shannon L.
    Recht, Michael
    Ragni, Margaret V.
    Yaish, Hassan M.
    Shapiro, Amy D.
    Yee, Donald L.
    Radulescu, Vlad Calin
    Santagostino, Elena
    Brown, Deborah
    BLOOD, 2017, 130
  • [48] Blood eosinophil subtype distribution following treatment with mepolizumab in patients with severe eosinophilic asthma
    Rimkunas, Airidas
    Januskevicius, Andrius
    Vasyle, Egle
    Palacionyte, Jolita
    Jermalaviciene, Inesa
    Miliauskas, Skaidrius
    Malakauskas, Kestutis
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [49] Timing to First Whole Blood Transfusion and Survival Following Severe Hemorrhage in Trauma Patients
    Torres, Crisanto M.
    Kenzik, Kelly M.
    Saillant, Noelle N.
    Scantling, Dane R.
    Sanchez, Sabrina E.
    Brahmbhatt, Tejal S.
    Dechert, Tracey A.
    Sakran, Joseph V.
    JAMA SURGERY, 2024, 159 (04) : 374 - 381
  • [50] Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration
    Garcea, G
    Jones, DJL
    Singh, R
    Dennison, AR
    Farmer, PB
    Sharma, RA
    Steward, WP
    Gescher, AJ
    Berry, DP
    BRITISH JOURNAL OF CANCER, 2004, 90 (05) : 1011 - 1015
12345